annual EBIT:
$1.29B-$199.71M(-13.38%)Summary
- As of today (September 14, 2025), RPRX annual earnings before interest & taxes is $1.29 billion, with the most recent change of -$199.71 million (-13.38%) on December 31, 2024.
- During the last 3 years, RPRX annual EBIT has fallen by -$138.27 million (-9.66%).
- RPRX annual EBIT is now -50.73% below its all-time high of $2.62 billion, reached on December 31, 2019.
Performance
RPRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$159.30M-$339.39M(-68.06%)Summary
- As of today (September 14, 2025), RPRX quarterly earnings before interest & taxes is $159.30 million, with the most recent change of -$339.39 million (-68.06%) on June 30, 2025.
- Over the past year, RPRX quarterly EBIT has dropped by -$84.09 million (-34.55%).
- RPRX quarterly EBIT is now -89.45% below its all-time high of $1.51 billion, reached on December 31, 2019.
Performance
RPRX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$1.93B-$84.09M(-4.17%)Summary
- As of today (September 14, 2025), RPRX TTM earnings before interest & taxes is $1.93 billion, with the most recent change of -$84.09 million (-4.17%) on June 30, 2025.
- Over the past year, RPRX TTM EBIT has increased by +$714.67 million (+58.76%).
- RPRX TTM EBIT is now -34.86% below its all-time high of $2.96 billion, reached on September 30, 2020.
Performance
RPRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RPRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.4% | -34.5% | +58.8% |
| 3 y3 years | -9.7% | -70.4% | +78.7% |
| 5 y5 years | -50.7% | -75.0% | -31.5% |
RPRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.4% | +40.0% | -81.8% | +128.3% | -4.2% | +361.9% |
| 5 y | 5-year | -50.7% | +40.0% | -81.8% | +128.3% | -34.9% | +361.9% |
| alltime | all time | -50.7% | +78.8% | -89.5% | +128.3% | -34.9% | +361.9% |
RPRX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $159.30M(-68.1%) | $1.93B(-4.2%) |
| Mar 2025 | - | $498.69M(+24.6%) | $2.02B(+29.5%) |
| Dec 2024 | $1.29B(-13.4%) | $400.11M(-54.2%) | $1.56B(-19.0%) |
| Sep 2024 | - | $872.86M(+258.6%) | $1.92B(+57.9%) |
| Jun 2024 | - | $243.39M(+509.1%) | $1.22B(-11.3%) |
| Mar 2024 | - | $39.96M(-94.8%) | $1.37B(-27.3%) |
| Dec 2023 | $1.49B(+61.7%) | $764.84M(+355.0%) | $1.89B(+237.4%) |
| Sep 2023 | - | $168.11M(-57.8%) | $559.36M(-15.1%) |
| Jun 2023 | - | $398.29M(-28.4%) | $658.64M(-17.6%) |
| Mar 2023 | - | $556.04M(-198.8%) | $798.92M(+91.1%) |
| Dec 2022 | $922.89M(-35.5%) | -$563.08M(-310.6%) | $418.02M(-61.4%) |
| Sep 2022 | - | $267.39M(-50.4%) | $1.08B(+0.1%) |
| Jun 2022 | - | $538.56M(+207.5%) | $1.08B(-22.0%) |
| Mar 2022 | - | $175.15M(+74.0%) | $1.39B(-1.5%) |
| Dec 2021 | $1.43B | $100.64M(-62.2%) | $1.41B(-17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $266.12M(-68.5%) | $1.71B(-18.5%) |
| Jun 2021 | - | $844.18M(+329.8%) | $2.10B(+11.0%) |
| Mar 2021 | - | $196.39M(-51.4%) | $1.89B(+1.8%) |
| Dec 2020 | $1.60B(-39.2%) | $404.47M(-38.3%) | $1.86B(-37.3%) |
| Sep 2020 | - | $655.70M(+3.1%) | $2.96B(+5.2%) |
| Jun 2020 | - | $636.16M(+291.1%) | $2.82B(+16.0%) |
| Mar 2020 | - | $162.68M(-89.2%) | $2.43B(-11.0%) |
| Dec 2019 | $2.62B(+92.3%) | $1.51B(+196.7%) | $2.73B(+123.7%) |
| Sep 2019 | - | $508.82M(+105.2%) | $1.22B(+71.5%) |
| Jun 2019 | - | $247.94M(-46.5%) | $711.30M(+53.5%) |
| Mar 2019 | - | $463.36M | $463.36M |
| Dec 2018 | $1.36B(+45.2%) | - | - |
| Dec 2017 | $939.69M(+30.0%) | - | - |
| Dec 2016 | $722.87M(-9.0%) | - | - |
| Dec 2015 | $794.28M | - | - |
FAQ
- What is Royalty Pharma plc annual earnings before interest & taxes?
- What is the all time high annual EBIT for Royalty Pharma plc?
- What is Royalty Pharma plc annual EBIT year-on-year change?
- What is Royalty Pharma plc quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Royalty Pharma plc?
- What is Royalty Pharma plc quarterly EBIT year-on-year change?
- What is Royalty Pharma plc TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Royalty Pharma plc?
- What is Royalty Pharma plc TTM EBIT year-on-year change?
What is Royalty Pharma plc annual earnings before interest & taxes?
The current annual EBIT of RPRX is $1.29B
What is the all time high annual EBIT for Royalty Pharma plc?
Royalty Pharma plc all-time high annual earnings before interest & taxes is $2.62B
What is Royalty Pharma plc annual EBIT year-on-year change?
Over the past year, RPRX annual earnings before interest & taxes has changed by -$199.71M (-13.38%)
What is Royalty Pharma plc quarterly earnings before interest & taxes?
The current quarterly EBIT of RPRX is $159.30M
What is the all time high quarterly EBIT for Royalty Pharma plc?
Royalty Pharma plc all-time high quarterly earnings before interest & taxes is $1.51B
What is Royalty Pharma plc quarterly EBIT year-on-year change?
Over the past year, RPRX quarterly earnings before interest & taxes has changed by -$84.09M (-34.55%)
What is Royalty Pharma plc TTM earnings before interest & taxes?
The current TTM EBIT of RPRX is $1.93B
What is the all time high TTM EBIT for Royalty Pharma plc?
Royalty Pharma plc all-time high TTM earnings before interest & taxes is $2.96B
What is Royalty Pharma plc TTM EBIT year-on-year change?
Over the past year, RPRX TTM earnings before interest & taxes has changed by +$714.67M (+58.76%)